AXGN vs PNR · rev $131.2M vs P/E 18, rev $4.18B
Axogen Inc (AXGN) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Axogen Inc (AXGN) is a medical devices company listed on US.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Latest reported AXGN revenue for 2026-06-30 was $131.2M. Net income was -$21.1M. AXGN currently screens at market cap $497.8M.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
AXGN currently screens at market cap $497.8M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the AXGN and PNR stock pages for the full models.
Not investment advice.